微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | -13.44% | -10.89% | -43.28% | 138/158 | 1.25% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | -9.38% | -8.82% | -116.63% | 139/158 | 0.28% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | -4.33% | -22.32% | 76.99% | 137/158 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -18.82% | -12.36% | -55.28% | 132/158 | -9.6% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | -12.12% | -19.41% | -40.6% | 138/158 | 4.24% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -8.62% | -11.95% | -143.5% | 138/158 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -3.54% | -53.91% | 78.87% | 135/158 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -16.75% | -56.25% | -65.02% | 130/158 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -10.15% | -82.88% | -31.82% | 131/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -7.7% | -91.07% | -234.78% | 131/158 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -2.3% | -45.57% | 78.54% | 129/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -10.72% | 60.5% | -93.15% | 124/158 | 0.72% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -5.55% | 2% | -37.72% | 123/158 | 2.84% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -4.03% | 2% | -155.06% | 129/158 | 2.19% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | -1.58% | 2% | 94.18% | 124/158 | 1.58% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -27.14% | 2% | 2% | 137/158 | 0.79% | ST人福 | 6.82% | 行业排名> |